Nicardipine Hydrochloride Injection
Product Images NDC 0143-9689

5 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Nicardipine Hydrochloride (NDC 0143-9689). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nicardipine Hydrochloride Injection 1)

Chemical Structure (Nicardipine Hydrochloride Injection 1)
Chemical structure of Nicardipine Hydrochloride. The diagram illustrates the molecular arrangement including various functional groups and the presence of hydrochloride (HCl), with chemical formula C26H29N3O6•HCl visible.*
FDA Label Image

Container Label 08-2015; Ndc Number Suffix Corrected To -01 (Nicardipine Hydrochloride Injection 2)

Container Label 08-2015; Ndc Number Suffix Corrected To -01 (Nicardipine Hydrochloride Injection 2)
Label for Nicardipine Hydrochloride Injection, 25 mg per 10 mL (2.5 mg/mL) intravenous injection. The vial is a 10 mL single dose container. The label includes instructions highlighting that the drug must be diluted before infusion and unused portions discarded. Manufactured by Exela Pharma Sciences, LLC and distributed by Hikma Pharmaceuticals USA Inc. Storage instructions specify protection from light and temperature control between 20 to 25°C (68 to 77°F).*
FDA Label Image

0.1 mg/ml Bag Corrected (Nicardipine Hydrochloride Injection 3)

0.1 mg/ml Bag Corrected (Nicardipine Hydrochloride Injection 3)
Label for Nicardipine Hydrochloride Injection 20 mg in 200 mL (0.1 mg/mL) in 0.9% Sodium Chloride, intended for intravenous infusion. The sterile, nonpyrogenic solution is supplied in a single-dose container with a caution to use immediately upon removal from overwrap. Manufactured by HIKMA Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

0l2 mg/ml Bag (Nicardipine Hydrochloride Injection 4)

0l2 mg/ml Bag (Nicardipine Hydrochloride Injection 4)
Label of Nicardipine Hydrochloride injection 40 mg in 200 mL (0.2 mg/mL) in 0.9% Sodium Chloride Injection for intravenous infusion. The sterile, nonpyrogenic solution is produced by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ. The label includes storage, dosage, and caution information as well as regulatory and barcode details.*
FDA Label Image

Layout 1 (Nicardipine Hydrochloride Injection 5)

Layout 1 (Nicardipine Hydrochloride Injection 5)
Barcode label showing GTIN 00301234567896, serial number 1234567890123, expiration date placeholder EXP MMYYYY, and lot number ABCDE12345, associated with Nicardipine Hydrochloride injection product labeling from Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.